Literature DB >> 7895220

Ovarian and endometrial cancers.

J W Mant1, M P Vessey.   

Abstract

Trends in the incidence and mortality of endometrial and ovarian cancer are described for England and Wales from 1950 to 1991 and for other selected countries from 1955 to 1985. The mortality from endometrial cancer has been falling in England and Wales since 1950 in all age groups. This has not been reflected by a decline in incidence. Most of the other countries show a similar decline in mortality in all ages but stable incidence rates. Mortality from ovarian cancer has been declining in women aged under 55 in England and Wales since the early 1970s but has been rising in women over 55. The international pattern is varied, but several countries show a decline in mortality in younger women that began in the early 1970s. The incidence in younger women has not fallen to the same degree. It is difficult to explain the trends in endometrial cancer mortality in terms of the known risk factors for the disease. The trends in ovarian cancer mortality are consistent with an effect of the combined oral contraceptive pill.

Entities:  

Keywords:  Biology; Cancer; Contraception; Contraceptive Methods--beneficial effects; Correlation Studies; Demographic Factors; Diseases; Endometrial Cancer; Family Planning; Hormone Replacement Therapy; Literature Review; Mortality; Mortality Decline--determinants; Neoplasms; Oral Contraceptives, Combined--beneficial effects; Oral Contraceptives--beneficial effects; Ovarian Cancer; Population; Population Dynamics; Research Methodology; Risk Factors; Statistical Studies; Studies; Treatment; World

Mesh:

Substances:

Year:  1994        PMID: 7895220

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  7 in total

Review 1.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

Authors:  Gwendal Lazennec
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  Expression of peptidylarginine deiminase type 4 in ovarian tumors.

Authors:  Lin Wang; Xiaotian Chang; Guangying Yuan; Yan Zhao; Pengcheng Wang
Journal:  Int J Biol Sci       Date:  2010-08-27       Impact factor: 6.580

3.  Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.

Authors:  Kurt J Sales; Vivien Grant; Ian H Cook; David Maldonado-Pérez; Richard A Anderson; Alistair R W Williams; Henry N Jabbour
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

4.  Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.

Authors:  M P Vessey; R Painter
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

5.  Trends in gynecologic cancer mortality in East Asian regions.

Authors:  Jung-Yun Lee; Eun-Yang Kim; Kyu-Won Jung; Aesun Shin; Karen K L Chan; Daisuke Aoki; Jae-Weon Kim; Jeffrey J H Low; Young-Joo Won
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

6.  Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.

Authors:  Kurt J Sales; David Maldonado-Pérez; Vivien Grant; Rob D Catalano; Martin R Wilson; Pamela Brown; Alistair R W Williams; Richard A Anderson; E Aubrey Thompson; Henry N Jabbour
Journal:  Biochim Biophys Acta       Date:  2009-10-09

7.  Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.

Authors:  Lakshmanaswamy Rajkumar; Raphael C Guzman; Jason Yang; Gudmundur Thordarson; Frank Talamantes; Satyabrata Nandi
Journal:  Breast Cancer Res       Date:  2003-11-11       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.